
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Philip Morris typically reports before the market opens, meaning Day 0 captures the first full trading session where investors react to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-22 | +$10.70 (+6.98%) | $8.70 (5.68%) | +$5.24 (+3.20%) | $7.18 (4.38%) |
| 2026-02-06 | +$0.81 (+0.45%) | $8.55 (4.70%) | -$0.98 (-0.54%) | $5.27 (2.88%) |
| 2025-10-21 | -$6.06 (-3.83%) | $13.59 (8.60%) | +$4.86 (+3.20%) | $5.96 (3.92%) |
| 2025-07-22 | -$15.21 (-8.43%) | $7.46 (4.13%) | -$0.60 (-0.36%) | $4.21 (2.55%) |
| 2025-04-23 | +$4.00 (+2.44%) | $5.55 (3.38%) | +$1.96 (+1.17%) | $4.05 (2.41%) |
| 2025-02-06 | +$14.34 (+10.95%) | $6.76 (5.16%) | -$0.91 (-0.63%) | $1.85 (1.27%) |
| 2024-10-22 | +$12.45 (+10.47%) | $8.75 (7.36%) | +$0.00 (+0.00%) | $2.38 (1.81%) |
| 2024-07-23 | +$2.34 (+2.18%) | $3.36 (3.13%) | +$1.88 (+1.72%) | $2.32 (2.12%) |
| Avg Abs Move | 5.72% | 5.27% | 1.35% | 2.67% |
PM's post-earnings price behavior has been highly volatile and directionally mixed over the past eight quarters. The stock has delivered an average absolute Day 0 move of 5.72%, with a wide range of outcomes—from an 8.43% decline in July 2025 to a 10.95% surge in February 2025. The average Day 0 range of 5.27% underscores the significant intraday volatility that typically accompanies PM's earnings releases.
Day +1 follow-through has been more muted, with an average absolute move of just 1.35% and an average range of 2.67%, suggesting most of the price discovery happens in the immediate reaction session. Notably, the most recent earnings release in April 2026 saw a 6.98% Day 0 gain with a relatively tight 5.68% range, followed by a 3.20% Day +1 advance—one of the stronger two-day performances in this dataset.
The pattern suggests PM is a high-conviction, high-volatility earnings play, where investors make decisive bets on results and guidance. The lack of a clear directional bias (the stock has moved both sharply higher and sharply lower on earnings) means positioning ahead of the release carries significant risk in either direction.
| Metric | Value |
|---|---|
| Expiration Date | 07/24/26 (DTE 3) |
| Expected Move | $8.63 (4.58%) |
| Expected Range | $179.74 to $197.00 |
| Implied Volatility | 75.15% |
The options market is pricing a 4.58% expected move for this week's expiration, which sits below the 5.72% average Day 0 move observed over the past eight earnings releases. This suggests options traders may be underestimating potential volatility, or alternatively, that recent quarters' outsized moves are not expected to repeat. Investors should be aware that historical earnings have frequently exceeded the implied move, particularly on the Day 0 reaction.
Analyst sentiment on Philip Morris is decisively bullish, with the consensus rating standing at 4.23 out of 5.0—firmly in Buy territory. The current breakdown shows 7 Strong Buy ratings, 2 Moderate Buy ratings, and 4 Hold ratings, with zero Sell or Strong Sell recommendations among the 13 analysts covering the stock. This lopsided distribution reflects broad confidence in PM's strategic transformation and earnings trajectory.
The average price target of $197.69 implies 5.1% upside from the current price of $188.04, with individual targets ranging from a low of $175.00 to a high of $210.00. The relatively tight clustering around the mean—compared to the wide range of possible outcomes—suggests analysts are largely aligned on the company's near-term valuation, though the high-end target of $210 indicates some see potential for further multiple expansion if smoke-free product momentum accelerates.
Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 4.23. This stability suggests analysts are comfortable with their current stance heading into earnings and are not making preemptive adjustments based on recent data points. The lack of downgrades or negative revisions is notable given the stock's strong run, indicating the Street believes the rally is justified by fundamentals rather than stretched on valuation.
Philip Morris is entering earnings with exceptionally strong technical momentum across all timeframes. The Barchart Technical Opinion currently stands at 100% Buy, a significant strengthening from 64% Buy one week ago and 72% Buy one month ago. This rapid improvement in the signal reflects powerful upside momentum as the stock has broken out to new highs.
Timeframe Analysis:
Trend Characteristics: The signal is characterized as Strong and Strengthening, indicating PM is in a robust uptrend with accelerating momentum—a technically supportive setup for an earnings catalyst.
The stock is trading at $188.04, positioned above all major moving averages: the 10-day ($185.05), 20-day ($183.20), 50-day ($182.34), 100-day ($174.39), and 200-day ($168.45). The only exception is the 5-day moving average at $188.89, which the stock is slightly below, suggesting a minor near-term pullback within the broader uptrend. The widening gap between the current price and longer-term averages—particularly the 200-day—underscores the strength of the rally over the past several months.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $188.89 | 50-Day MA | $182.34 |
| 10-Day MA | $185.05 | 100-Day MA | $174.39 |
| 20-Day MA | $183.20 | 200-Day MA | $168.45 |
The technical setup is overwhelmingly supportive heading into earnings, with PM in a confirmed uptrend across all relevant timeframes and trading well above key moving averages. The 100% Buy signal across short, medium, and long-term horizons suggests the path of least resistance remains higher, though the stock's proximity to the 5-day moving average indicates some very short-term consolidation. Investors should note that the strong technical backdrop raises the bar for a positive earnings reaction—any disappointment could trigger profit-taking given the extended nature of the rally. Conversely, a beat-and-raise scenario could fuel a breakout to new all-time highs, with the next resistance zone likely in the low-to-mid $190s based on the current trajectory.